Improved Lipid Metabolism: The upregulation of peroxisome proliferator-activated receptor alpha (PPARα) and lipoprotein lipase (LPL) expression enhances fatty acid oxidation and lipid clearance, while reduced fatty acid synthase (FAS) expression decreases lipogenesis and steatosis [38]. The gene discussed is FASN; the disease is steatosis.